The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2,4-Difluoro-N-(2-methoxy-5-(3-oxo-4-(pyridin-4-ylmethyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)pyridin-3-yl)benzenesulfonamide ID: ALA4244021
PubChem CID: 145984030
Max Phase: Preclinical
Molecular Formula: C26H20F2N4O5S
Molecular Weight: 538.53
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1ncc(-c2ccc3c(c2)N(Cc2ccncc2)C(=O)CO3)cc1NS(=O)(=O)c1ccc(F)cc1F
Standard InChI: InChI=1S/C26H20F2N4O5S/c1-36-26-21(31-38(34,35)24-5-3-19(27)12-20(24)28)10-18(13-30-26)17-2-4-23-22(11-17)32(25(33)15-37-23)14-16-6-8-29-9-7-16/h2-13,31H,14-15H2,1H3
Standard InChI Key: AJJIMBIWPUTLAP-UHFFFAOYSA-N
Molfile:
RDKit 2D
38 42 0 0 0 0 0 0 0 0999 V2000
1.2667 -11.4332 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.6833 -10.7208 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
0.8579 -10.7161 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.6875 -12.3749 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6875 -13.1999 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.3995 -13.6082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1115 -13.1999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1115 -12.3749 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3995 -11.9582 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8249 -13.6168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8217 -14.4427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5314 -14.8562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5378 -13.2043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2522 -13.6223 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2455 -14.4500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9549 -14.8673 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.6756 -14.4615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6824 -13.6339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9683 -13.2120 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.4006 -13.2279 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.3995 -11.1333 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.6850 -9.8958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4062 -9.4845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4067 -8.6603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6916 -8.2528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9748 -8.6639 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9779 -9.4868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9718 -11.9644 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.2585 -12.3790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9739 -12.3870 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6911 -11.9793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1195 -9.8991 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.6905 -7.4302 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
7.4023 -12.3989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1191 -11.9919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1250 -11.1661 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.4083 -10.7489 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6945 -11.1583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 1 0
4 9 2 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
10 11 1 0
10 13 2 0
11 12 2 0
12 15 1 0
14 13 1 0
7 10 1 0
14 15 2 0
14 19 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
18 20 2 0
9 21 1 0
21 2 1 0
2 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
4 28 1 0
28 29 1 0
19 30 1 0
30 31 1 0
23 32 1 0
25 33 1 0
31 34 2 0
34 35 1 0
35 36 2 0
36 37 1 0
37 38 2 0
38 31 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 538.53Molecular Weight (Monoisotopic): 538.1122AlogP: 4.16#Rotatable Bonds: 7Polar Surface Area: 110.72Molecular Species: NEUTRALHBA: 7HBD: 1#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 6.59CX Basic pKa: 5.01CX LogP: 2.64CX LogD: 2.13Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.38Np Likeness Score: -1.84
References 1. Dong FD, Liu DD, Deng CL, Qin XC, Chen K, Wang J, Song HR, Ding HW.. (2018) Design, synthesis and biological evaluation of novel series of 2H-benzo[b][1,4]oxazin-3(4H)-one and 2H-benzo[b][1,4]oxazine scaffold derivatives as PI3Kα inhibitors., 26 (14): [PMID:29937355 ] [10.1016/j.bmc.2018.06.022 ]